HomePAR • ASX
add
Paradigm Biopharmaceuticals Ltd
Nakaraang pagsara
$0.34
Sakop ng araw
$0.33 - $0.34
Sakop ng taon
$0.26 - $0.66
Market cap
139.27M AUD
Average na Volume
905.17K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | -8.35K | — |
Gastos sa pagpapatakbo | 8.49M | 13.50% |
Net na kita | -6.42M | -47.47% |
Net profit margin | 76.93K | — |
Kita sa bawat share | — | — |
EBITDA | -8.46M | -13.58% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 16.82M | -5.87% |
Kabuuang asset | 24.57M | -13.40% |
Kabuuang sagutin | 3.39M | -5.49% |
Kabuuang equity | 21.18M | — |
Natitirang share | 397.43M | — |
Presyo para makapag-book | 6.80 | — |
Return on assets | -86.45% | — |
Return on capital | -100.25% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.42M | -47.47% |
Cash mula sa mga operasyon | -3.89M | 47.90% |
Cash mula sa pag-invest | 0.00 | 100.00% |
Cash mula sa financing | -62.10K | 1.06% |
Net change in cash | -3.98M | 49.40% |
Malayang cash flow | -5.25M | -17.86% |
Tungkol
Itinatag
2014
Website
